Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry

OBJECTIVE: To describe the profile of patients with multiple sclerosis (MS) treated with fingolimod in Spain and to assess the effectiveness and safety of fingolimod after 4 years of inclusion in the Spanish Gilenya Registry. METHODS: An observational, retrospective/prospective, multicenter case reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Meca-Lallana, J. E., Oreja-Guevara, C., Muñoz, D., Olascoaga, J., Pato, A., Ramió-Torrentà, L., Meca-Lallana, V., Hernández, M. A., Marzo, M. E., Álvarez- Cermeño, J. C., Rodríguez-Antigüedad, A., Montalbán, X., Fernández, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513911/
https://www.ncbi.nlm.nih.gov/pubmed/34644366
http://dx.doi.org/10.1371/journal.pone.0258437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513911/
https://www.ncbi.nlm.nih.gov/pubmed/34644366
http://dx.doi.org/10.1371/journal.pone.0258437

Ejemplares similares